🚀 Announcement from Thinkhat! 🚀 At Thinkhat, we are building platforms that transform innovative concepts into successful companies through ideation, incubation, and illumination. Leveraging artificial intelligence and machine learning (AI/ML), opportune investments, and strategic partnerships, we are unlocking new possibilities across the continuum of life sciences (upstream) and healthcare (downstream). The healthcare and life sciences (HLS) industry needs a collective reimagining of patient care to improve outcomes. Our goal is to create an integrated HLS ecosystem with platforms offering personalized, accessible, and accelerated solutions. Over the past two years, our team of scientists, researchers, ML engineers, strategists, and developers have built a portfolio of 10+ initiatives addressing key issues and opportunities. Healthcare operational inefficiencies: Nearly $1 trillion in healthcare spending is lost to inefficiencies. Our AI solutions reclaim these resources, reducing provider burnout, enhancing patient care, and creating a more sustainable healthcare eco-system. Cell and gene therapies: We are using AI to accelerate research in iPSCs, CRISPR, and mRNA technologies while simultaneously addressing rising costs associated with traditional therapeutic development. Personalized & precision medicine: We are employing AI/ML to better understand and analyze omics data—genomics, proteomics, and metabolomics, combined with patients’ longitudinal health records to create AI-informed personalized health profiles, patient journey mapping, and digital twins that facilitate customized therapies and care. Care beyond clinical settings: Our "preventative" at-home AI companions, care coordinators, and non-intrusive continuous health monitoring systems with human-in-the-loop are extending patient care beyond traditional hospital settings. Mental health: Our AI mental health platforms, alongside care providers, offer continuous support to patients, easing healthcare system strain by identifying symptom progression early. Early detection and longevity: Our AI platforms integrate non-intrusive monitoring and behavioral analytics to provide real-time feedback, empowering patients to manage their health proactively and enabling doctors to support healthier, longer lives. At the recent HLTH conference, we showcased our innovative solutions to an engaged audience of industry leaders, healthcare providers, and technology pioneers. The event was a tremendous success, with Thinkhat’s vision for an AI-driven HLS industry gaining significant traction and generating numerous partnership opportunities for future collaborations. Join us on this exciting journey as we reimagine the future of HLS together. Stay tuned for updates and opportunities to engage with our initiatives. Together, we can make a difference! 🌟 #Thinkhat #HealthcareInnovation #PersonalizedMedicine #CRISPR #mRNA #PhysicianBurnout #AIInHealthcare #LifeSciences #ReimaginingCare
About us
At Thinkhat, we are building platforms that transform innovative concepts into successful companies through ideation, incubation, and illumination. Leveraging artificial intelligence and machine learning (AI/ML), opportune investments, and strategic partnerships, we are unlocking new possibilities across the continuum of life sciences (upstream) and healthcare (downstream). In the past 24 months, we have established robust healthcare and life sciences platforms, laying a solid foundation with a global team of over 120 specialists: scientists, researchers, machine learning engineers, strategists, full-stack developers, and UI/UX designers. Our 2024 portfolio (Cohort 1) includes over 10 initiatives addressing critical issues, such as Operational inefficiencies in health systems Alleviating physician burnout and administrative burdens Creating sequence-as-a-service solutions for targeted diseases Advancing personalized precision medicine Conducting R&D in CRISPR and mRNA for novel cell and gene therapies To learn more, visit www.thinkhat.ai.
- Website
-
https://www.thinkhat.ai/
External link for Thinkhat
- Industry
- Venture Capital and Private Equity Principals
- Company size
- 51-200 employees
- Headquarters
- Puerto Rico
- Type
- Privately Held
- Founded
- 2021
- Specialties
- Healthcare, Life Sciences, AI, ML, Startup Studio, and Venture Capital
Locations
-
Primary
Puerto Rico, US
-
Office 1255, 1000 N. West Street
Suite 1200
Wilmington, Delaware 19801, US
-
HITEC City
Q3/A1, 9th Floor, Cyber Towers
Hyderabad, Telangana 500081, IN
-
London, GB
Employees at Thinkhat
Updates
-
As ViVE 2025 comes to a close, the conversation around GenAI in healthcare is shifting from potential to execution. While AI’s impact is clear, the challenge remains—how do we move beyond pilot programs to enterprise-wide adoption and real transformation? Eric Malamud represented Thinkhat alongside leaders from NODE.Health, CHAI, and MedStar Health, tackling this issue head-on. The discussion focused on scaling AI-driven solutions to ensure real impact, not just experimentation. ViVE continues to bring together the brightest minds in digital health, creating a space for real conversations about the future of AI and healthcare innovation. As the industry moves forward, we’re committed to driving these discussions beyond the conference and into execution. #GenAI #DigitalHealth #VIVE25 #AITransformation #InnovationToExecution #ThinkhatVentureStudio #AIinHealthcare #HealthcareInnovation
-
-
Thank you to Fox40 for featuring the announcement of our life science portfolio companies - nCode Biosciences, DxBio, and Renue Life Sciences. If you’re attending the PMWC - Precision Medicine World Conference 2025, come see us at our dedicated hub to learn more. https://lnkd.in/gX_Z6d_Y #PMWC2025 #PrecisionMedicine #AIinHealthcare #ThinkhatVentureStudio #HealthcareInnovation
-
Our team is at day two of PMWC - Precision Medicine World Conference 2025, where we’re unveiling our life science portfolio and engaging in conversations about the future of AI-powered precision medicine, CRISPR innovation, and next-gen therapeutics. Join us at our Thinkhat Hub to learn more about our initiatives and to connect with our team! Ravi Lam, Richard Hosein, Sierra Joy Varela, Sam Perli, Eric Malamud, Kimberly Sharp, Denise Holzer, Phani Kukutla Ph.D. #PMWC2025 #PrecisionMedicine #AIinHealthcare #ThinkhatVentureStudio #HealthcareInnovation
-
-
We’re excited to share that Ravi Lam, CEO & Founder of Thinkhat, will be presenting the 2025 PMWC Pioneer Award to Dr. Paul J. Chang, Professor and Vice-Chair of Radiology at the University of Chicago, at this year’s PMWC - Precision Medicine World Conference. Dr. Chang’s groundbreaking contributions to medical imaging and informatics have shaped the future of precision medicine, aligning with Thinkhat’s mission to drive AI-driven innovation in healthcare and life sciences. Join us at PMWC 2025 from February 5-7 as we celebrate pioneers who are redefining the future of medicine. Richard Hosein, Sierra Joy Varela, Sam Perli, Eric Malamud, Denise Holzer, Akash Solaraju, Phani Kukutla Ph.D., Kimberly Sharp #PMWC2025 #AIinHealthcare #ThinkhatVentureStudio #HealthcareInnovation
-
-
We’re thrilled to be in San Francisco for the J.P. Morgan Healthcare Conference having conversations about the future of healthcare and AI! Are you attending this week? We’d love to connect with fellow leaders and investors who are passionate about driving innovation in digital health, AI-powered healthcare solutions, and life sciences. At Thinkhat, we’re dedicated to leveraging advanced technologies to transform clinical workflows, accelerate pharmaceutical development, and enhance patient outcomes. If this aligns with your vision, let’s start a conversation! Ravi Lam, Richard Hosein, Eric Malamud, Sam Perli, Denise Holzer, Akash Solaraju and Phani Kukutla Ph.D. #JPMWeek #JPMConference #ThinkhatVentureStudio #HealthcareInnovation #LifeSciences #DigitalHealth
-
-
We are excited to share our recent participation in the Global Healthcare Leaders Foundation (GHLF) soft launch event in Boston on Friday, May 17th. The GHLF, founded by alumni of Harvard Medical School's Global Health Care Leaders Program, is dedicated to advancing value-based healthcare worldwide. GHLF aims to empower 150+ global healthcare leaders and Harvard GHLP alumni from across 50+ countries, harnessing their collective expertise to catalyze initiatives and projects focused on elevating patient outcomes, empowering communities, and driving transformative change within the healthcare industry, fostering a more equitable and accessible global healthcare landscape. Our core team had the privilege of connecting with healthcare leaders, thinkers, and visionaries at the event to discuss impactful solutions that aim to elevate standards and revolutionize patient care. Here are a few glimpses of the soft launch event! #HealthcareInnovation #GlobalHealthcare #GHLF #PatientOutcomes #Leadership #GHLP
-